High Rates of Non-Relapse Mortality and Graft-Versus-Host Disease in Patient Undergoing Allogeneic Stem Cell Transplantation (ASCT) Following Non-Myeloablative (NMA) Conditioning With TLI/ATG
Abraham S. Kanate(HonorHealth), Mehdi Hamadani(Medical College of Wisconsin), Lubna N. Chaudhary(Medical College of Wisconsin), Scot C. Remick(University Hospitals of Cleveland), Laura F. Gibson(West Virginia University), Deirdre Bulian(West Virginia University), Michael Craig(Edith Cowan University), Jame Abraham(Cleveland Clinic), Pamela Bunner(West Virginia University), Aaron Cumpston(West Virginia University Hospitals), William Tse(University of Louisville), Sonia Leadmon(West Virginia University)
Cited by 0
Related Papers
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
|Transplantation and Cellular Therapy|2020|718
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
|Journal of Clinical Oncology|2017|664
Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease
|Journal of Clinical Oncology|2019|441